DCT
1:21-cv-00314
Bayer Pharma AG v. Lupin Ltd
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (11/16/22)
Patent Owner
Operating Company (W)
PACER
1:21-cv-00314
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
03/03/21 - 09/06/24 | 36% |
Magistrate
Mary Pat Thynge
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L5 A | |
L5 B | |
L5 A | |
L2 C | |
L2 E | |
L3 B | |
L5 A | |
L4 A | |
L1 B | |
L1 C | |
L1 D | |
-- -- -- |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L5 E | |
L5 D | |
L5 D | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L3 E | |
L3 E | |
L2 E | |
L1 D | |
-- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L5 E | |
L5 B | |
L5 E | |
Shaw Keller LLPLocal | L4 D |
L5 A | |
L5 E | |
L5 E | |
Morris James LLPLocal | L4 E |
L5 E | |
L1 B | |
L4 E | |
L5 E | |
L5 E | |
L3 C | |
L5 D | |
L4 B | |
L4 C | |
L4 D | |
L2 D | |
L1 D | |
-- -- -- | |
L3 D | |
L5 A | |
L3 A | |
-- -- -- | |
L3 E | |
L5 E | |
L5 E | |
L2 C | |
L2 A | |
L1 C | |
Abrams & Bayliss LLPLocal | L2 D |
L4 E | |
L1 D | |
L2 E | |
L3 C | |
L2 B | |
L2 E |
No Attorneys